Track topics on Twitter Track topics that are important to you
The U.S. Patent and Trademark Office has issued Patent No. 5,858,351 to Avigen Inc. and Johns Hopkins University covering the in vivo administration of any gene into skeletal, smooth or cardiac muscle...
Avigen is a leader in the development of gene therapy products derived from adeno-associated virus ("AAV") for the treatment of inherited diseases. Avigen's proposed gene therapy products are designed...
Avigen is a biopharmaceutical company focused on developing and commercializing small molecule therapeutics to treat serious neurological disorders, including neuropathic pain and neuromuscular sp...
The Automation Partnership (TAP) is a world leader in design, development and implementation of advanced industrial automation solutions to the life sciences - pharmaceutical, biotechnology and genomi...
We have published hundreds of Avigen, Inc. news stories on BioPortfolio along with dozens of Avigen, Inc. Clinical Trials and PubMed Articles about Avigen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avigen, Inc. Companies in our database. You can also find out about relevant Avigen, Inc. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...